Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Cell Reports|May 18, 2017
The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 LigandsHugo G Hilton, Curtis P McMurtrey, Alex S Han, et al.Cell Reports|March 2, 2022
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cellsQuirin Hammer, Josefine Dunst, Wanda Christ, et al.Science (New York, N.Y.)|January 6, 2018
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.Nature Immunology|July 2, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneityLucas Rebuffet, Janine E Melsen, Bertrand Escalière, et al.Blood Advances|November 26, 2019
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AMLBérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, et al.Cancer Discovery|July 3, 2024
Single-Cell View of Tumor Microenvironment Gradients in Pleural MesotheliomaBruno Giotti, Komal Dolasia, William Zhao, et al.European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.Immunity|June 8, 2020
Immunology of COVID-19: Current State of the ScienceNicolas Vabret, Graham J Britton, Conor Gruber, et al.Science Translational Medicine|October 5, 2018
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individualsMathieu Uzzan, Minami Tokuyama, Adam K Rosenstein, et al.Nature Immunology|April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancerMatthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.Pageof 9